Single-Dose Radiation During Lumpectomy May Equal Postoperative Radiotherapy
Single-dose targeted intraoperative radiotherapy offers comparable long-term control to whole-breast radiation for early breast cancer
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Single-dose targeted intraoperative radiotherapy offers comparable long-term control to whole-breast radiation for early breast cancer
Breast cancer diagnosed within a year of a negative mammography may be more likely to metastasise than tumours detected during screening
Patients with stage IB–IIIA non-small-cell lung cancer may benefit from neoadjuvant atezolizumab and chemotherapy
CheckMate 358 study data suggest that neoadjuvant nivolumab may delay progression in some patients with high-risk resectable Merkel cell carcinoma
TAILORx has quantified the impact of adjuvant endocrine therapy given with or without chemotherapy on cognitive impairment in women with early-stage breast cancer
Women with early triple-negative breast cancer may benefit from a capecitabine-based adjuvant chemotherapy regimen
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.